Point-of-care testing of hyponatremia and hypernatremia levels: An optoplasmonic biosensing approach
PLOS One · 2025
DOI: 10.1371/journal.pone.0319559 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Abdullah Mohammad Tanvirul Hoque und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Wyant College of Optical Sciences, The University of Arizona, Tucson, Arizona, United States of America. Hauptthemen laut MEDLINE: Hyponatremia, Hypernatremia, Point-of-Care Testing, Biosensing Techniques. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In the human body, sodium ion (Na + ) is the principal extracellular cation and its imbalance in blood or lymph results in either hyponatremia or hypernatremia conditions. Any of these scenarios have fatal effects on a patient’s health over time. However, the existing technologies limit quick point-of-care (POC) testing options. To overcome the challenges associated with prompt diagnosis, we proposed a photonic crystal fiber (PCF) based surface plasmon resonance (SPR) sensor for in situ rapid testing of Na + ion levels in patient’s blood samples. A unique PCF sensor with a modified square lattice is engineered to achieve a propagation-controlled core that permits enhanced control over wave guidance resulting in improved sensing performance. Plasmonically active conducting indium tin oxide (ITO) is used to omit the limitations that arise from undesired oxidation with time and to enable higher spectral tunability. The finite element method (FEM) is used to perform the numerical analysis on performance and all sensor parameters are optimized to ensure the best sensing outcome. The structural asymmetry-induced birefringence enforced a superior y-polarized sensing response compared to that of the x-polarized mode for the proposed sensor, where it proffers the highest wavelength sensitivity of 15,157 nm/RIU with a detection resolution of 6.61 × 10 −6 RIU. Additionally, the sensor exhibits a maximum amplitude sensitivity of 470 RIU −1 and an outstanding figure of merit (FOM) of 171 RIU −1 . Due to the high sensitivity and resolution, we infer that the proposed sensor will be a promising POC alternative to the conventional serum electrolyte panels used in present medical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Wyant College of Optical Sciences, The University of Arizona, Tucson, Arizona, United States of America.
- Department of Electrical and Electronic Engineering, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh.
- Department of Electrical Engineering, The Pennsylvania State University, University Park, Pennsylvania, United States of America.
- Faculty of Science & Technology, Charles Darwin University, Darwin, Northern Territory, Australia.
- The Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, California, United States of America.
- School of Medicine, Stanford University, Palo Alto, California, United States of America.
ORCID-Profile: Abrar Islam
Zitieren
APA
Hoque, A. M. T., Islam, A., Haider, F., Aoni, R. A., & Ahmed, R. (2025). Point-of-care testing of hyponatremia and hypernatremia levels: An optoplasmonic biosensing approach. PLOS One. https://doi.org/10.1371/journal.pone.0319559
Vancouver
Hoque AMT, Islam A, Haider F, Aoni RA, Ahmed R. Point-of-care testing of hyponatremia and hypernatremia levels: An optoplasmonic biosensing approach. PLOS One. 2025. doi:10.1371/journal.pone.0319559
BibTeX
@article{Hoque2025,
author = {Hoque, Abdullah Mohammad Tanvirul and Islam, Abrar and Haider, Firoz and Aoni, Rifat Ahmmed and Ahmed, Rajib},
title = {Point-of-care testing of hyponatremia and hypernatremia levels: An optoplasmonic biosensing approach},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0319559}
}
EUVIMED